본문 바로가기
KERD
논문KCI 등재

The modulation of pulmonary group 2 innate lymphoid cell function in asthma: from inflammatory mediators to environmental and metabolic factors

Thio Christina Li-Ping|Chang Ya-Jen
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 1872-1884|DOI 10.1038/s12276-023-01021-0

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

A dysregulated type 2 immune response is one of the fundamental causes of allergic asthma. Although Th2 cells are undoubtedly central to the pathogenesis of allergic asthma, the discovery of group 2 innate lymphoid cells (ILC2s) has added another layer of complexity to the etiology of this chronic disease. Through their inherent innate type 2 responses, ILC2s not only contribute to the initiation of airway inflammation but also orchestrate the recruitment and activation of other members of innate and adaptive immunity, further amplifying the inflammatory response. Moreover, ILC2s exhibit substantial cytokine plasticity, as evidenced by their ability to produce type 1- or type 17-associated cytokines under appropriate conditions, underscoring their potential contribution to nonallergic, neutrophilic asthma. Thus, understanding the mechanisms of ILC2 functions is pertinent. In this review, we present an overview of the current knowledge on ILC2s in asthma and the regulatory factors that modulate lung ILC2 functions in various experimental mouse models of asthma and in humans.

Abstract

A dysregulated type 2 immune response is one of the fundamental causes of allergic asthma. Although Th2 cells are undoubtedly central to the pathogenesis of allergic asthma, the discovery of group 2 innate lymphoid cells (ILC2s) has added another layer of complexity to the etiology of this chronic disease. Through their inherent innate type 2 responses, ILC2s not only contribute to the initiation of airway inflammation but also orchestrate the recruitment and activation of other members of innate and adaptive immunity, further amplifying the inflammatory response. Moreover, ILC2s exhibit substantial cytokine plasticity, as evidenced by their ability to produce type 1- or type 17-associated cytokines under appropriate conditions, underscoring their potential contribution to nonallergic, neutrophilic asthma. Thus, understanding the mechanisms of ILC2 functions is pertinent. In this review, we present an overview of the current knowledge on ILC2s in asthma and the regulatory factors that modulate lung ILC2 functions in various experimental mouse models of asthma and in humans.

참고문헌 (174)

  1. Diseases, G. B. D., "Global burden of 369 diseases and injuries in 204countries and territories, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019", Lancet, 396, pp.1204~1222 (2020)
  2. Dharmage, S. C., "Epidemiology of asthma in children and adults", Front. Pediatr, 7, pp.246~ (2019)
  3. Kaur, R., "Phenotypes and endotypes of adult asthma : moving toward precision medicine", J. Allergy Clin. Immunol, 144, pp.1~12 (2019)
  4. Kuruvilla, M. E., "Understanding asthma phenotypes, endotypes, and mechanisms of disease", Clin. Rev. Allergy Immunol, 56, pp.219~233 (2019)
  5. Fahy, J. V., "Type 2 inflammation in asthma-present in most, absent in many", Nat. Rev. Immunol, 15, pp.57~65 (2015)
  6. Rodriguez-Rodriguez, N., "Group 2 innate lymphoid cells: team players in regulating asthma", Annu. Rev. Immunol, 39, pp.167~198 (2021)
  7. Ricardo-Gonzalez, R. R., "Tissue signals imprint ILC2 identity with anticipatory function", Nat. Immunol, 19, pp.1093~1099 (2018)
  8. Kabata, H., "The group 2 innate lymphoid cell(ILC2)regulatory network and its underlying mechanisms", Immunol. Rev, 286, pp.37~52 (2018)
  9. Wong, S. H., "Transcription factor RORalpha is critical for nuocyte development", Nat. Immunol, 13, pp.229~236 (2012)
  10. Zhou, L., "Striking similarity : GATA-3 regulates ILC2 and Th2 cells", Immunity, 37, pp.589~591 (2012)
  11. Califano, D., "Transcription factor Bcl11b controls identity and function of mature type 2 innate lymphoid cells", Immunity, 43, pp.354~368 (2015)
  12. Klein Wolterink, R. G., "Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma", Eur. J. Immunol, 42, pp.1106~1116 (2012)
  13. Monticelli, L. A., "Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus", Nat. Immunol, 12, pp.1045~1054 (2011)
  14. Wilhelm, C., "An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation", Nat. Immunol, 12, pp.1071~1077 (2011)
  15. Doherty, T. A., "STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria", Am. J. Physiol. Lung Cell Mol. Physiol, 303, pp.L577~L588 (2012)
  16. Halim, T. Y., "Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation", Immunity, 36, pp.451~463 (2012)
  17. Wu, Y. H., "Pulmonary IL-33 orchestrates innate immune cells to mediate respiratory syncytial virus-evoked airway hyperreactivity and eosinophilia", Allergy, 75, pp.818~830 (2020)
  18. Chang, Y. J., "Innate lymphoid cells mediate influenza-induced airway hyperreactivity independently of adaptive immunity", Nat. Immunol, 12, pp.631~638 (2011)
  19. Kumar, R. K., "Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations", J. Leukoc. Biol, 96, pp.391~396 (2014)
  20. Halim, T. Y., "Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses", Nat. Immunol, 17, pp.57~64 (2016)
  21. Wang, L., "Single-cell transcriptomic analysis reveals the immune landscape of lung in steroid-resistant asthma exacerbation", Proc. Natl. Acad. Sci. USA, 118, pp.e2005590118~ (2021)
  22. Kabata, H., "Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation", Nat. Commun, 4, pp.2675~ (2013)
  23. Castanhinha, S., "Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33", J. Allergy Clin. Immunol, 136, pp.312~322 (2015)
  24. Christianson, C. A., "Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33", J. Allergy Clin. Immunol, 136, pp.59~68 (2015)
  25. Smith, S. G., "Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia", J. Allergy Clin. Immunol, 137, pp.75~86 (2016)
  26. Liu, T., "Type 2 innate lymphoid cells : a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma", Respir. Med, 109, pp.1391~1396 (2015)
  27. Bartemes, K. R., "Enhanced innate type 2immune response in peripheral blood from patients with asthma", J. Allergy Clin. Immunol, 134, pp.671~678 (2014)
  28. Liu, S., "Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin", J. Allergy Clin. Immunol, 141, pp.257~268 (2018)
  29. Chen, R., "Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma", Am. J. Respir. Crit. Care Med, 196, pp.700~712 (2017)
  30. Machida, K., "The role of the TL1A", DR3 axis in the activation of group 2innate lymphoid cells in subjects with eosinophilic asthma, 2020, pp.202, 1105~1114
  31. Yu, Q. N., "Increased group 2 innate lymphoid cells are correlated with eosinophilic granulocytes in patients with allergic airway inflammation", Int. Arch. Allergy Immunol, 176, pp.124~132 (2018)
  32. Nagakumar, P., "Type 2 innate lymphoid cells in induced sputum from children with severe asthma", J. Allergy Clin. Immunol, 137, pp.624~626 (2016)
  33. Jia, Y., "IL-13(+)type 2 innate lymphoid cells correlate with asthma control status and treatment response", Am. J. Respir. Cell Mol. Biol, 55, pp.675~683 (2016)
  34. Yu, Q. N., "ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma", Allergy, 73, pp.1860~1870 (2018)
  35. Xie, Y., "Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma", Allergy, 76, pp.2797~2808 (2021)
  36. Nagakumar, P., "Pulmonary type-2 innate lymphoid cells in paediatric severe asthma : phenotype and response to steroids", Eur. Respir. J, 54, pp.1801809~ (2019)
  37. van der Ploeg, E. K., "Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases", Sci. Immunol, 6, pp.eabd3489~ (2021)
  38. Barlow, J. L., "IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes(type 2 innate lymphoid cells)and airway contraction", J. Allergy Clin. Immunol, 132, pp.933~941 (2013)
  39. Hardman, C. S., "IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation", Eur. J. Immunol, 43, pp.488~498 (2013)
  40. Morita, H., "An interleukin-33-mast cell-interleukin-2 axis suppresses papaininduced allergic inflammation by promoting regulatory T cell numbers", Immunity, 43, pp.175~186 (2015)
  41. Moussion, C., "The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?", PLoS One, 3, pp.e3331~ (2008)
  42. Mindt, B. C., "The NF-kappaB transcription factor c-Rel modulates group 2innate lymphoid cell effector functions and drives allergic airway inflammation", Front. Immunol, 12, pp.664218~ (2021)
  43. Furusawa, J., "Critical role of p38 and GATA3 in natural helper cell function", J. Immunol, 191, pp.1818~1826 (2013)
  44. Bartemes, K. R., "IL-33-responsive lineage-CD25+ CD44(hi)lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs", J. Immunol, 188, pp.1503~1513 (2012)
  45. Steer, C. A., "Lung group 2 innate lymphoid cells are trained by endogenous IL-33 in the neonatal period", JCI Insight, 5, pp.e135961~ (2020)
  46. Stier, M. T., "IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow", J. Exp. Med, 215, pp.263~281 (2018)
  47. Tang, W., "IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma", Int. Arch Allergy Immunol, 163, pp.5~10 (2014)
  48. Bankova, L. G., "The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation", Sci. Immunol, 3, pp.eaat9453~ (2018)
  49. Huang, Y., "S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense", Science, 359, pp.114~119 (2018)
  50. Huang, Y., "IL-25-responsive, lineage-negative KLRG1(hi)cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells", Nat. Immunol, 16, pp.161~169 (2015)
  51. Moro, K., "Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+)lymphoid cells", Nature, 463, pp.540~544 (2010)
  52. Neill, D. R., "Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity", Nature, 464, pp.1367~1370 (2010)
  53. Spolski, R., "The gamma (c) family of cytokines: finetuning signals from IL-2 and IL-21 in the regulation of the immune response", F1000Res, 6, pp.1872~ (2017)
  54. Roediger, B., "IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation", J. Allergy Clin. Immunol, 136, pp.1653~1663 (2015)
  55. Mohapatra, A., "Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis", Mucosal Immunol, 9, pp.275~286 (2016)
  56. Thio, C. L., "The ketone body betahydroxybutyrate mitigates ILC2-driven airway inflammation by regulating mast cell function", Cell Rep, 40, pp.111437~ (2022)
  57. Shinoda, K., "Thy1+IL-7+ lymphatic endothelial cells in iBALT provide a survival niche for memory T-helper cells in allergic airway inflammation", Proc. Natl. Acad. Sci. USA, 113, pp.E2842~E2851 (2016)
  58. Kalia, V., "Regulation of effector and memory CD8 T cell differentiation by IL-2-A balancing act", Front. Immunol, 9, pp.2987~ (2018)
  59. Motomura, Y., "Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation", Immunity, 40, pp.758~771 (2014)
  60. Noval Rivas, M., "IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function", J. Allergy Clin. Immunol, 138, pp.801~811 (2016)
  61. Turner, J. E., "IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation", J. Exp. Med, 210, pp.2951~2965 (2013)
  62. Bal, S. M., "IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs", Nat. Immunol, 17, pp.636~645 (2016)
  63. Camelo, A., "IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells", Blood Adv, 1, pp.577~589 (2017)
  64. Varricchi, G., "Thymic stromal lymphopoietin isoforms, inflammatory disorders, and cancer", Front. Immunol, 9, pp.1595~ (2018)
  65. Dahlgren, M. W., "Adventitial stromal cells define group 2 innate lymphoid cell tissue niches", Immunity, 50, pp.707~722 (2019)
  66. Meylan, F., "TL1A and DR3, a TNF family ligandreceptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation", Immunol. Rev, 244, pp.188~196 (2011)
  67. Meylan, F., "The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells", Mucosal Immunol, 7, pp.958~968 (2014)
  68. Yu, X., "TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers", Mucosal Immunol, 7, pp.730~740 (2014)
  69. Aggarwal, B. B., "Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey", Blood, 119, pp.651~665 (2012)
  70. Hurrell, B. P., "TNFR2 signaling enhances ILC2 survival, function, and induction of airway hyperreactivity", Cell Rep, 29, pp.4509~4524 (2019)
  71. Galli, S. J., "The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others", Am. J. Pathol, 142, pp.965~974 (1993)
  72. Makowska, J. S., "Stem cell factor and its soluble receptor(c-kit)in serum of asthmatic patients-correlation with disease severity", BMC Pulm. Med, 9, pp.27~ (2009)
  73. Fonseca, W., "Group 2 innate lymphoid cells(ILC2)are regulated by stem cell factor during chronic asthmatic disease", Mucosal Immunol, 12, pp.445~456 (2019)
  74. Mjosberg, J. M., "Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161", Nat. Immunol, 12, pp.1055~1062 (2011)
  75. Gorski, S. A., "Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection", PLoS Pathog, 9, pp.e1003615~ (2013)
  76. Kudo, F., "Interferon-gamma constrains cytokine production of group 2innate lymphoid cells", Immunology, 147, pp.21~29 (2016)
  77. Maazi, H., "Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity", J. Allergy Clin. Immunol, 141, pp.893~905 (2018)
  78. Moro, K., "Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses", Nat. Immunol, 17, pp.76~86 (2016)
  79. Stegemann-Koniszewski, S., "Respiratory influenza A virus infection triggers local and systemic natural killer cell activation via toll-like receptor 7", Front. Immunol, 9, pp.245~ (2018)
  80. Duerr, C. U., "Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells", Nat. Immunol, 17, pp.65~75 (2016)
  81. Cautivo, K. M., "Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation", Immunity, 55, pp.254~271 (2022)
  82. McHedlidze, T., "IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells", Mucosal Immunol, 9, pp.1384~1394 (2016)
  83. Okuzumi, S., "TLR7 agonist suppresses group 2 innate lymphoid cellmediated inflammation via IL-27-producing interstitial macrophages", Am. J. Respir. Cell Mol. Biol, 65, pp.309~318 (2021)
  84. Iyer, S. S., "Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease", Crit. Rev. Immunol, 32, pp.23~63 (2012)
  85. Ogasawara, N., "IL-10, TGF-beta, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells", J. Allergy Clin. Immunol, 141, pp.1147~1151 (2018)
  86. Rigas, D., "Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulatorinducible T-cell costimulator ligand interaction", J. Allergy Clin. Immunol, 139, pp.1468~1477 (2017)
  87. Seehus, C. R., "Alternative activation generates IL-10 producing type 2 innate lymphoid cells", Nat. Commun, 8, pp.1900~ (2017)
  88. Howard, E., "IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity", J. Allergy Clin. Immunol, 147, pp.1281~1295 (2021)
  89. Wang, L., "TGF-beta induces ST2 and programs ILC2 development", Nat. Commun, 11, pp.35~ (2020)
  90. Denney, L., "Pulmonary epithelial cell-derived cytokine TGF-beta1 is a critical cofactor for enhanced innate lymphoid cell function", Immunity, 43, pp.945~958 (2015)
  91. Zhang, J., "Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity", Nat. Immunol, 23, pp.237~250 (2022)
  92. Silver, J. S., "Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs", Nat. Immunol, 17, pp.626~635 (2016)
  93. Ohne, Y., "IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity", Nat. Immunol, 17, pp.646~655 (2016)
  94. Golebski, K., "IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation", Nat. Commun, 10, pp.2162~ (2019)
  95. Zhang, K., "Cutting edge : notch signaling promotes the plasticity of group-2innate lymphoid cells", J. Immunol, 198, pp.1798~1803 (2017)
  96. Hochdorfer, T., "Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells", Eur. J. Immunol, 49, pp.884~893 (2019)
  97. Schauberger, E., "Lipid mediators of allergic disease : pathways, treatments, and emerging therapeutic targets", Curr. Allergy Asthma Rep, 16, pp.48~ (2016)
  98. Doherty, T. A., "Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production", J. Allergy Clin. Immunol, 132, pp.205~213 (2013)
  99. Zhou, Y., "Prostaglandin E(2)inhibits group 2 innate lymphoid cell activation and allergic airway inflammation through E-prostanoid 4-cyclic adenosine monophosphate signaling", Front. Immunol, 9, pp.501~ (2018)
  100. Barnig, C., "Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma", Sci. Transl. Med, 5, pp.174ra126~ (2013)
  101. Zhou, W., "Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses", Am. J. Respir. Crit. Care Med, 193, pp.31~42 (2016)
  102. Fajt, M. L., "Prostaglandin D(2)pathway upregulation : relation to asthma severity, control, and TH2 inflammation", J. Allergy Clin. Immunol, 131, pp.1504~1512 (2013)
  103. Hardman, C., "Fevipiprant, a selective prostaglandin D(2)receptor 2antagonist, inhibits human group 2 innate lymphoid cell aggregation and function", J. Allergy Clin. Immunol, 143, pp.2329~2333 (2019)
  104. Xue, L., "Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells", J. Allergy Clin. Immunol, 133, pp.1184~1194 (2014)
  105. Oyesola, O. O., "The prostaglandin D(2)receptor CRTH2 promotes IL-33-induced ILC2 accumulation in the lung", J. Immunol, 204, pp.1001~1011 (2020)
  106. Maric, J., "Prostaglandin E(2) suppresses human group 2 innate lymphoid cell function", J. Allergy Clin. Immunol, 141, pp.1761~1773 (2018)
  107. Robb, C. T., "Metabolic regulation by prostaglandin E(2)impairs lung group 2 innate lymphoid cell responses", Allergy, 78, pp.714~730 (2022)
  108. Zhou, W., "COX inhibition increases alternaria-induced pulmonary group 2innate lymphoid cell responses and IL-33 release in mice", J. Immunol, 205, pp.1157~1166 (2020)
  109. Simons, B., "PGI2 controls pulmonary NK cells that prevent airway sensitization to house dust mite allergen", J. Immunol, 198, pp.461~471 (2017)
  110. von Moltke, J., "Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s", J. Exp. Med, 214, pp.27~37 (2017)
  111. Cai, T., "IL-17-producing ST2(+) group 2 innate lymphoid cells play a pathogenic role in lung inflammation", J. Allergy Clin. Immunol, 143, pp.229~244 (2019)
  112. Salimi, M., "Cysteinyl leukotriene E(4) activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D(2) and epithelial cytokines", J. Allergy Clin. Immunol, 140, pp.1090~1100 (2017)
  113. Xiong, Y., "BLT1 signaling in epithelial cells mediates allergic sensitization via promotion of IL-33 production", Allergy, 74, pp.495~506 (2019)
  114. Blake, K. J., "Neuronal regulation of immunity in the skin and lungs", Trends. Neurosci, 42, pp.537~551 (2019)
  115. Nussbaum, J. C., "Type 2 innate lymphoid cells control eosinophil homeostasis", Nature, 502, pp.245~248 (2013)
  116. Talbot, S., "Silencing nociceptor neurons reduces allergic airway inflammation", Neuron, 87, pp.341~354 (2015)
  117. Wallrapp, A., "The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation", Nature, 549, pp.351~356 (2017)
  118. Klose, C. S. N., "The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation", Nature, 549, pp.282~286 (2017)
  119. Cardoso, V., "Neuronal regulation of type 2 innate lymphoid cells via neuromedin U", Nature, 549, pp.277~281 (2017)
  120. Sui, P., "Pulmonary neuroendocrine cells amplify allergic asthma responses", Science, 360, pp.eaan8546~ (2018)
  121. Wallrapp, A., "Calcitonin gene-related peptide negatively regulates alarmindriven type 2 innate lymphoid cell responses", Immunity, 51, pp.709~723 (2019)
  122. Nagashima, H., "Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation", Immunity, 51, pp.682~695 (2019)
  123. Moriyama, S., "beta(2)-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses", Science, 359, pp.1056~1061 (2018)
  124. Mashimo, M., "Regulation of immune functions by non-neuronal acetylcholine(ACh)via muscarinic and nicotinic ACh receptors", Int. J. Mol. Sci, 22, pp.6818~ (2021)
  125. Brown, D. A., "Acetylcholine and cholinergic receptors", Brain Neurosci. Adv, 3, pp.2398212818820506~ (2019)
  126. Chu, C., "The ChAT-acetylcholine pathway promotes group 2 innate lymphoid cell responses and anti-helminth immunity", Sci. Immunol, 6, pp.eabe3218~ (2021)
  127. Roberts, L. B., "Acetylcholine production by group 2 innate lymphoid cells promotes mucosal immunity to helminths", Sci. Immunol, 6, pp.eabd0359~ (2021)
  128. Roberts, L. B., "Differential regulation of allergic airway inflammation by acetylcholine", Front. Immunol, 13, pp.893844~ (2022)
  129. Galle-Treger, L., "Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity", Nat. Commun, 7, pp.13202~ (2016)
  130. Yuan, F., "A selective alpha7 nicotinic acetylcholine receptor agonist, PNU-282987, attenuates ILC2s activation and alternaria-induced airway inflammation", Front. Immunol, 11, pp.598165~ (2020)
  131. Cephus, J. Y., "Testosterone attenuates group 2 innate lymphoid cellmediated airway inflammation", Cell Rep, 21, pp.2487~2499 (2017)
  132. Mikkonen, L., "Androgen receptor and androgen-dependent gene expression in lung", Mol. Cell Endocrinol, 317, pp.14~24 (2010)
  133. Blanquart, E., "Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1", J. Allergy Clin. Immunol, 149, pp.237~251 (2022)
  134. Bartemes, K., "IL-33-responsive group 2innate lymphoid cells are regulated by female sex hormones in the uterus", J. Immunol, 200, pp.229~236 (2018)
  135. Cephus, J. Y., "Estrogen receptor-alpha signaling increases allergen-induced IL-33 release and airway inflammation", Allergy, 76, pp.255~268 (2021)
  136. Zein, J. G., "Asthma is different in women", Curr. Allergy Asthma Rep, 15, pp.28~ (2015)
  137. Han, J., "Hypoxia induces adrenomedullin from lung epithelia, stimulating ILC2 inflammation and immunity", J. Exp. Med, 219, pp.e20211985~ (2022)
  138. Toki, S., "Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo", J. Allergy Clin. Immunol, 142, pp.1515~1528 (2018)
  139. Maazi, H., "ICOS : ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity", Immunity, 42, pp.538~551 (2015)
  140. Kamachi, F., "ICOS promotes group 2innate lymphoid cell activation in lungs", Biochem. Biophys. Res. Commun, 463, pp.739~745 (2015)
  141. Morita, H., "Immune checkpoint molecules on ILC2s as potential therapeutic targets for allergic diseases", J. Allergy Clin. Immunol, 149, pp.60~62 (2022)
  142. Galle-Treger, L., "Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes", Nat. Commun, 10, pp.713~ (2019)
  143. Helou, D. G., "PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity", Nat. Commun, 11, pp.3998~ (2020)
  144. Shafiei-Jahani, P., "CD200-CD200R immune checkpoint engagement regulates ILC2 effector function and ameliorates lung inflammation in asthma", Nat. Commun, 12, pp.2526~ (2021)
  145. Soskic, B., "CD80 on human T cells is associated with FoxP3 expression and supports treg homeostasis", Front. Immunol, 11, pp.577655~ (2020)
  146. Harjunpaa, H., "TIGIT as an emerging immune checkpoint", Clin. Exp. Immunol, 200, pp.108~119 (2020)
  147. Qin, S., "Novel immune checkpoint targets : moving beyond PD-1 and CTLA-4", Mol. Cancer, 18, pp.155~ (2019)
  148. Tian, J., "The role of GITR", GITRL interaction in autoimmune diseases, 2020, pp.11, 588682~
  149. Nagashima, H., "GITR cosignal in ILC2s controls allergic lung inflammation", J. Allergy Clin. Immunol, 141, pp.1939~1943 (2018)
  150. Gosset, P., "Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients", Int. Arch. Allergy Immunol, 106, pp.69~77 (1995)
  151. Karta, M. R., "beta(2) integrins rather than beta(1) integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung", J. Allergy Clin. Immunol, 141, pp.329~338 (2018)
  152. Lei, A. H., "ICAM-1 controls development and function of ILC2", J. Exp. Med, 215, pp.2157~2174 (2018)
  153. Hurrell, B. P., "Distinct roles of LFA-1 and ICAM-1 on ILC2s control lung infiltration, effector functions, and development of airway hyperreactivity", Front. Immunol, 11, pp.542818~ (2020)
  154. Perkins, T. N., "RAGEdependent VCAM-1 expression in the lung endothelium mediates IL-33-induced allergic airway inflammation", Allergy, 74, pp.89~99 (2019)
  155. Wilhelm, C., "Metabolic regulation of innate lymphoid cell-mediated tissue protection-linking the nutritional state to barrier immunity", Front. Immunol, 8, pp.1742~ (2017)
  156. Surace, L., "Dichotomous metabolic networks govern human ILC2 proliferation and function", Nat. Immunol, 22, pp.1367~1374 (2021)
  157. Galle-Treger, L., "Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function", J. Allergy Clin. Immunol, 145, pp.502~517 (2020)
  158. Karagiannis, F., "Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation", Immunity, 52, pp.620~634 (2020)
  159. Fali, T., "Metabolic regulation by PPARgamma is required for IL-33-mediated activation of ILC2s in lung and adipose tissue", Mucosal Immunol, 14, pp.585~593 (2021)
  160. Yamaguchi, M., "Macrophages regulate lung ILC2 activation via Pla2g5-dependent mechanisms", Mucosal Immunol, 11, pp.615~626 (2018)
  161. Monticelli, L. A., "Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation", Nat. Immunol, 17, pp.656~665 (2016)
  162. Panda, S. K., "SLC7A8 is a key amino acids supplier for the metabolic programs that sustain homeostasis and activation of type 2 innate lymphoid cells", Proc. Natl. Acad. Sci. USA, 119, pp.e2215528119~ (2022)
  163. Fu, L., "A mitochondrial STAT3-methionine metabolism axis promotes ILC2-driven allergic lung inflammation", J. Allergy Clin. Immunol, 149, pp.2091~2104 (2022)
  164. Li, Q., "E3 ligase VHL promotes group 2 innate lymphoid cell maturation and function via glycolysis inhibition and induction of interleukin-33 receptor", Immunity, 48, pp.258~270 (2018)
  165. Stein, M. M., "Innate immunity and asthma risk in amish and hutterite farm children", N. Engl. J. Med, 375, pp.411~421 (2016)
  166. Tei, R., "TLR3-driven IFN-beta antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung", J. Allergy Clin. Immunol, 149, pp.1044~1059 (2022)
  167. Thio, C. L., "Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid celldriven airway hyperreactivity", J. Allergy Clin. Immunol, 144, pp.682~697 (2019)
  168. Ishii, T., "Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics", Clin. Exp. Allergy, 49, pp.1624~1632 (2019)
  169. Block, K. E., "Physiological microbial exposure transiently inhibits mouse lung ILC2 responses to allergens", Nat. Immunol, 23, pp.1703~1713 (2022)
  170. Wendell, S. G., "Fatty acids, inflammation, and asthma", J. Allergy Clin. Immunol, 133, pp.1255~1264 (2014)
  171. Trompette, A., "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis", Nat. Med, 20, pp.159~166 (2014)
  172. Thio, C. L., "Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate", J. Allergy Clin. Immunol, 142, pp.1867~1883 (2018)
  173. Lewis, G., "Dietary fiber-induced microbial short chain fatty acids suppress ILC2-dependent airway inflammation", Front. Immunol, 10, pp.2051~ (2019)
  174. Saito, E. R., "A novel ketone-supplemented diet improves recognition memory and hippocampal mitochondrial efficiency in healthy adult mice", Metabolites, 12, pp.1019~ (2022)

관련 논문AI추천

The Roles of Innate Lymphoid Cells in the Development of Asthma김혜영, 우연덕, 정동진, 정두현대한면역학회 · Immune Network2014 · 제14권 제4호Interactions between NCR + ILC3s and the Microbiome in the Airways Shape Asthma Severity강혜련, 김영찬, 김지현, 김혜영, 박재현, 배용수, 백민경, 손경희, 양시영, 원성호, 이하나, 정두현, 조상현, 최성미, 함종호대한면역학회 · Immune Network2021 · 제21권 제4호Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation김혜영, Kim Jinwoo, Lim MinYeong, Ryu Seungwon생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 선천성 면역반응과 천식김혜영대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2014 · 제2권 제5호알레르기질환에서의 Type 2 Innate Lymphoid Cell의 역할모지훈대한천식알레르기학회 · 천식 및 알레르기2012 · 제32권 제4호Tissue-Specific Metabolic Reprogramming in Innate Lymphoid Cells and Its Impact on Disease김혜영, 양우석, 함종호대한면역학회 · Immune Network2025 · 제25권 제1호

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기